Showing results (141-150 of 181) with videos related to
Sort By:
Pageof 19
Molecular Cancer Therapeutics|May 9, 2012
Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cellsC Elizabeth Caldon, C Marcelo Sergio, Jian Kang, et al.Clinical Lung Cancer|August 2, 2024
Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving ImmunotherapiesMargaret R Smith, Yuezhu Wang, Caroline B Dixon, et al.The American Journal of Pathology|March 24, 2012
Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27Meimei Wan, Weiwei Huang, Timothy E Kute, et al.Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
CT-X antigen expression in human breast cancerAnita Grigoriadis, Otavia L Caballero, Keith S Hoek, et al.Oncology Reports|April 22, 2008
Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancerBeth O Van Emburgh, Jennifer J Hu, Edward A Levine, et al.Cancer Research|January 21, 2006
In utero exposure of mice to dibenzo[a,l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptorZhen Yu, Christiane V Loehr, Kay A Fischer, et al.Journal for Immunotherapy of Cancer|May 19, 2017
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapySacha Gnjatic, Vincenzo Bronte, Laura Rosa Brunet, et al.Hepatology (Baltimore, Md.)|September 22, 2005
Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profilingSuk Woo Nam, Jik Young Park, Adaikalavan Ramasamy, et al.Annals of Surgical Oncology|March 2, 2023
Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy ControlsPaul A Vallejos, Amber Gonda, Jingjing Yu, et al.Journal of Cancer Prevention|January 20, 2022
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: ReportAltaf Mohammed, Roderick H Dashwood, Sally Dickinson, et al.Pageof 19